CAR T-Cells in Multiple Myeloma Are Ready for Prime Time
Keywords:
Área de Medicina Clínica y Epidemiología
Relapse and refractory multiple myeloma
B-cell maturation antigen
Chimeric antigen receptor T cell (CAR T-cell) therapy
Immunotherapy
Note:
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution
Citation:
Rodríguez-Otero, P. (Paula); Prósper-Cardoso, F. (Felipe Luis); Alfonso-Piérola, A. (Ana); et al. "CAR T-Cells in Multiple Myeloma Are Ready for Prime Time". Journal of Clinical Medicine. 9 (11), 2020, 3577
Statistics and impact
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.